26 May 2013
Keywords: benefits, bayer, nisoldipine, shown, defiant, ii, study
Article | 20 January 1997
A major, multicenter study has shown no increase in cardiac events ormortality in post-myocardial infarction patients treated with Bayer's
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
13 January 1997
27 January 1997
24 May 2013
© 2013 thepharmaletter.com